Edition:
India

People: TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

5.66USD
23 Apr 2018
Change (% chg)

$-0.05 (-0.96%)
Prev Close
$5.71
Open
$5.69
Day's High
$5.77
Day's Low
$5.66
Volume
77,551
Avg. Vol
529,974
52-wk High
$7.00
52-wk Low
$3.50

Krassan, Mitchell 

Mr. Mitchell L. Krassan is Executive Vice President, Chief Strategy Officer of TherapeuticsMD, Inc., since October 2011. He has served as Executive Vice President and Chief Strategy Officer of our company since October 2011. From April 2010 to October 2011, Mr. Krassan served as Chief Strategy and Performance Officer of VitaMed. Mr. Krassan has been a partner with EquiMark Limited, a private investment partnership, since October 1997. From November 1994 to July 1997, Mr. Krassan served as Chief Financial Officer and Chief Operating Officer of The Reich Group/Telespectrum Worldwide, a fully integrated direct marketing firm that provided clients expertise in market research and analysis, strategic planning, marketing, creative, and production services, telemarketing and database development. Mr. Krassan earned a B.S. in Accounting from the University of Maryland, received his certification as a CPA in the state of Maryland, and earned his M.B.A. in Management from New York University.

Basic Compensation

Total Annual Compensation, USD 300,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 165,608
Fiscal Year Total, USD 465,608

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 22,500 144,238.00
Name Fiscal Year Total

Tommy Thompson

203,753

John Milligan

784,079

Robert Finizio

1,263,350

Daniel Cartwright

651,566

Mitchell Krassan

465,608

Michael Donegan

374,676
As Of  31 Dec 2016